Press Releases

Exact Sciences Corp., a global leader in cancer diagnostics, today announced new data on its cancer tests and treatment guidance tools will be showcased in seven presentations and one e-abstract at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, being held virtually June 4-8. Data presented will reinforce the value of the Oncotype DX® tests in informing personalized treatment decisions and highlight industry research from Thrive, an Exact Sciences company, outlining

Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that the U.S. Patent and Trademark Office (“USPTO”) issued to Navidea U.S. patent 11,007,272, entitled “Compounds and Methods for Diagnosis and Treatment of Viral Infections,” with protection to October 7, 2037. This patent protects the use of Navidea’s mannosylated dextran-based drug delivery vehicles to de

Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) are pleased to report positive interim Phase 2 clinical trial safety and immunogenicity data for Medicago’s plant-derived COVID-19 vaccine candidate, which has been tested in combination with GSK’s pandemic adjuvant. These results are part of the ongoing Phase 2/3 study and reiterate the promising profile observed during Phase 1 testing. Immunogenicity, as measured by the neutralizing ant

Sharp, a part of UDG Healthcare and a leading provider of pharmaceutical packaging and clinical services, has appointed Robert O’Beirn as SVP and Managing Director of its global Clinical Services business. Mr O’Beirn joined UDG Healthcare ten years ago as senior legal counsel, later becoming Director of Corporate Development focusing on Mergers and Acquisitions.  In early 2019 he joined the Sharp Senior Leadership team, serving as Managing Director of Sharp’s

LANXESS India has committed over INR 2.1 crores as part of its CSR spends to support the medical infrastructure in the country in its fight against the Coronavirus pandemic. The spike in COVID-19 cases in the second wave has been severe and there has been a huge demand for critical medical equipment for treating patients. To help medical institutions tackle the situation better, LANXESS India has donated twenty units of advanced German Ventilators worth approximately INR 1.9 crores to hospita

Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced today the acquisition of a majority stake in Finar Limited. Finar is a leading manufacturer, supplier, and distributor of pharmaceutical excipients, lab chemicals, aquaculture inputs, and food grade additives. The acquisition complements Aceto’s growth strategy, enhancing and expanding the company’s manufacturing footprint, R&D capabilities, and quality expe

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced its launch of the first available generic version, in the U.S., of THIOLA® (tiopronin) tablets, indicated, in combination with high fluid intake, alkali, and diet modification, for the prevention of cystine (kidney) stone formation in adults and pediatric patients 9 years of age and older with severe homozygous cystinuria, who are not responsive to these measures alone.

Pharma and biotech laboratories performing high-throughput screening, high-content screening and molecular cell biology can now benefit from a series of new automated incubators and storage solutions that offer a large capacity, fast access and wide temperature range, while helping eliminate contamination issues in high-throughput environments. The Thermo Scientific Cytomat 24 automated incubators and storage systems bring the latest incubation technology to large capacity microplat

QIAGEN N.V. announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the fast and easy-to-use QIAreach® Anti-SARS-CoV-2 Total Test. The authorization means QIAGEN can start making its portable antibody testing device available to health-care professionals in the U.S. Each antibody test takes only about 10 minutes to identify whether a person carries antibodies to the SARS-CoV-2 virus as a result of prior infection. Individu

ProtoKinetix, Incorporated, a clinical-stage biomedical company, today announced its collaboration with IQVIA to accelerate development of AAGP® (PKX-001) in ocular conditions, specifically Dry Eye Disease and Wet and Dry forms of Age-related Macular Degeneration. The ProtoKinetix-IQVIA collaboration will aim to accelerate the clinical development and regulatory progress of PKX-001. The collaboration is expected to drive directed clinical development as PKX-001 enters Phase 1 te